Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN Druckformat: 2151-8017
ISSN Online: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.v1.i4.40
pages 297-305

Post-Translational Regulation of Fas/CD95 in Cell Death and Survival: Role of Nitric Oxide

L. Leon-Bollotte
EPHE, Laboratoire d'immunologie et immunothérapie des cancers, University of Burgundy, Dijon
M. Lamrani
EPHE, Laboratoire d'immunologie et immunothérapie des cancers, University of Burgundy, Dijon
S. Plenchette-Colas
EPHE, Laboratoire d'immunologie et immunothérapie des cancers, University of Burgundy, Dijon
Jean-Francois Jeannin
EPHE Tumor Immunology and Immunotherapy, Laboratory, University of Burgundy, Dijon, France
Ali Bettaieb
École Pratique des Hautes Études (EPHE), PSL Research University, Paris, France; Laboratoire d'Immunologie et Immunothérapie des Cancers (LIIC), Université de Bourgogne Franche-Comté, Dijon, France

ABSTRAKT

Fas/CD95 or APO-1 is one of the best-characterized members of the tumor necrosis factor receptor (TNFR) superfamily. Triggering of Fas by its ligand (FasL) leads to receptor oligomerization and the formation of the death-induced signaling complex (DISC), and thereby activates the caspase cascade, which culminates in apoptotic cell death. Many post-translational modifications are recognized as critical modifications for the early events of Fas regulation and function. Here, we summarize the current knowledge on Fas post-translational modifications, including phosphorylation, nitration, palmitoylation, and glutathionylation.


Articles with similar content:

The Proteasome and Its Inhibitors in Immune Regulation and Immune Disorders
Critical Reviews™ in Immunology, Vol.26, 2006, issue 6
Alberto Ballestrero, Franco Patrone, Frank Grunebach, Alessio Nencioni, Peter Brossart
Dual Roles of Kruppel-Like Factor 4 as a Tumor Suppressor or Oncogene
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Peng-Sheng Zheng, Wen-Ting Yang
Brain-Derived Neurotrophic Factor Activation of TrkB Protects Neurons from HIV-1/gp120-Induced Cell Death
Critical Reviews™ in Neurobiology, Vol.16, 2004, issue 1&2
Alessia Bachis, Italo Mocchetti
KLF4 in Ovarian Cancer
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Lawrence M. Pfeffer, Baojin Wang, Ziyun Du, Junming Yue
Regulation of Estrogen Receptor α Function in Breast Cancer
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 1
Nancy E. Davidson, Anne T. Ferguson